Literature DB >> 4869637

The reacquisition of staphylococci by treated carriers: a demonstration of bacterial interference.

R R Martin, A White.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4869637

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  9 in total

Review 1.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.

Authors:  J Kluytmans; A van Belkum; H Verbrugh
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris.

Authors:  Hongliang Zhao; Kristina Blazanovic; Yoonjoo Choi; Chris Bailey-Kellogg; Karl E Griswold
Journal:  Appl Environ Microbiol       Date:  2014-02-21       Impact factor: 4.792

3.  Effect of BMY-28100, a new cephalosporin, on Staphylococcus aureus nasal carriage.

Authors:  R L Atmar; M L Allen; J Freiman; C Kiefe; S Ehrman; S B Greenberg
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

4.  Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.

Authors:  K E Quickel; R Selden; J R Caldwell; N F Nora; W Schaffner
Journal:  Appl Microbiol       Date:  1971-09

5.  In vitro susceptibility of Corynebacterium diphtheriae to thirteen antibiotics.

Authors:  R C Gordon; M D Yow; D J Clark; W B Stephenson
Journal:  Appl Microbiol       Date:  1971-03

6.  Quantitative nasal culture: a tool in antibiotic research.

Authors:  R R Martin; A White
Journal:  Appl Microbiol       Date:  1971-09

7.  Staphylococcus aureus in Antarctica: carriage and attempted eradication.

Authors:  S J Krikler
Journal:  J Hyg (Lond)       Date:  1986-12

8.  High-level potentiation of lysostaphin anti-staphylococcal activity by lysozyme.

Authors:  G Cisani; P E Varaldo; G Grazi; O Soro
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

9.  Quantitative nasal cultures from carriers of Staphylococcus aureus: effects of oral therapy with erythromycin, rosamicin, and placebo.

Authors:  S Z Wilson; R R Martin; M Putman; S B Greenberg; R J Wallace; J G Jemsek
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.